Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $1.43 million. The enterprise value is -$11.33 million.
| Market Cap | 1.43M |
| Enterprise Value | -11.33M |
Important Dates
The last earnings date was Thursday, April 4, 2024, after market close.
| Earnings Date | Apr 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GLMD has 3.81 million shares outstanding.
| Shares Outstanding | 3.81M |
| Owned by Insiders (%) | 3.87% |
| Owned by Institutions (%) | 9.44% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.10 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.81, with zero debt.
| Current Ratio | 4.81 |
| Quick Ratio | 4.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 12.92 |
Financial Efficiency
Return on equity (ROE) is -53.30% and return on invested capital (ROIC) is -53.98%.
| Return on Equity (ROE) | -53.30% |
| Return on Assets (ROA) | -44.40% |
| Return on Capital (ROIC) | -53.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.73M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.09% in the last 52 weeks. The beta is 0.87, so GLMD's price volatility has been lower than the market average.
| Beta (1Y) | 0.87 |
| 52-Week Price Change | -92.09% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 53.70 |
| Average Volume (30 Days) | 215,648 |
Short Selling Information
| Short Interest | 39,240 |
| Short Previous Month | 6,207 |
| Short % of Shares Out | 0.68% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.49M |
| Pretax Income | -6.91M |
| Net Income | -6.91M |
| EBITDA | -7.46M |
| EBIT | -7.49M |
| Earnings Per Share (EPS) | -$2.50 |
Balance Sheet
The company has $12.76 million in cash and no debt, giving a net cash position of $12.76 million or $3.35 per share.
| Cash & Cash Equivalents | 12.76M |
| Total Debt | n/a |
| Net Cash | 12.76M |
| Net Cash Per Share | $3.35 |
| Equity / Book Value | 13.88M |
| Book Value Per Share | 3.65 |
| Working Capital | 10.49M |
Cash Flow
| Operating Cash Flow | -6.14M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.14M |
| FCF Per Share | -$2.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -65.23% |
| Shareholder Yield | -65.23% |
| Earnings Yield | -482.72% |
| FCF Yield | -428.60% |
Analyst Forecast
The average price target for GLMD is $4.00, which is 963.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 963.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 15, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | May 15, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |